For PFS | P value | Hazard ratio | 95 % CI |
---|---|---|---|
Age | 0.947 | 1.014 | 0.674–1.524 |
Chemotherapy cycles | 0.531 | 1.063 | 0.879–1.285 |
Primary site | 0.001 | 1.839 | 1.296–2.610 |
Degree of differentiation | 0.809 | 1.031 | 0.808–1.315 |
Local/distant metastasis | 0.478 | 1.238 | 0.687–2.229 |
p-STAT3 expression levels | 0.009 | 0.554 | 0.356–0.862 |
For OS | P value | Hazard ratio | 95 % CI |
Age | 0.810 | 0.899 | 0.598–1.352 |
Chemotherapy cycles | 0.899 | 1.012 | 0.844–1.212 |
Primary site | 0.050 | 1.431 | 0.999–2.049 |
Degree of differentiation | 0.041 | 0.761 | 0.586–0.990 |
Local/distant metastasis | 0.302 | 1.380 | 0.748–2.543 |
p-STAT3 expression levels | 0.161 | 0.732 | 0.473–1.132 |